Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupiwei Xieyinhuo Shengyang supplemented decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of chronic fatigue syndrome (CFS). It is a multi-herb decoction, meaning it consists of several different herbal ingredients combined according to TCM principles. The formula aims to tonify Qi, nourish Yin, and support Yang—concepts in TCM that relate to energy balance and organ function. Clinical studies suggest it may help reduce fatigue symptoms and improve clinical symptom scores in CFS patients when used as monotherapy or adjunctive therapy[1][8]. The precise mechanism of action is not fully elucidated by modern pharmacology but is believed to involve modulation of immune function, enhancement of energy metabolism, and regulation of neuroendocrine-immune networks according to TCM theory[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bupiwei Xieyinhuo Shengyang supplemented decoction.